Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

NCT00354913 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Gliosarcoma

Interventions

DRUG: hydroxyurea
DRUG: imatinib mesylate

Sponsor

Duke University

Collaborators

[object Object]
[object Object]